ABP 215

Generic Name: ABP 215
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20110216non-squamous non-small cell lung cancer, metastatic colorectal cancer, glioblastoma, and metastatic renal cell carcinoma1Randomized, Single-Blind, Single-Dose, 3-Arm, Parallel Group Study to Determine the Pharmacokinetics of ABP 215 and Bevacizumab (AvastinĀ®) in Healthy Male Subjects
20120265Non-small Cell Lung Cancer3A randomized, double-blind, phase 3 study evaluating the efficacy and safety of ABP 215 compared with bevacizumab in subjects with advanced non-small cell lung cancer